The safety of <font color="red">whey_2</font> <font color="red">protein_2</font> <font color="red">concentrate_2</font> <font color="red">derived_2</font> <font color="red">from_2</font> <font color="red">the_2</font> <font color="red">milk_2</font> <font color="red">of_2</font> <font color="red">cows_2</font> <font color="red">immunized_2</font> <font color="red">against_2</font> <font color="red">Clostridium_2</font> <font color="red">difficile_2</font> <font color="red">._2</font> 
<br>
<br> A <font color="red">whey_1</font> <font color="red">protein_1</font> <font color="red">concentrate_1</font> <font color="red">prepared_1</font> <font color="red">from_1</font> <font color="red">the_1</font> <font color="red">milk_1</font> <font color="red">of_1</font> <font color="red">cows_1</font> <font color="red">that_1</font> <font color="red">have_1</font> <font color="red">been_1</font> <font color="red">immunized_1</font> <font color="red">against_1</font> <font color="red">Clostridium_1</font> <font color="red">difficile_1</font> <font color="red">(_1</font> <font color="red">C._1</font> <font color="red">difficile_1</font> <font color="red">)_1</font> <font color="red">and_1</font> <font color="red">its_1</font> <font color="red">toxins_1</font> <font color="red">,_1</font> <font color="red">toxin_1</font> <font color="red">A_1</font> <font color="red">and_1</font> <font color="red">toxin_1</font> <font color="red">B_1</font> <font color="red">,_1</font> is produced for use as a medical food for the dietary management of patients with C. difficile - associated diarrhea ( CDAD ) to prevent a relapse of the infection . The safety of <font color="red">anti_2</font> <font color="red">-_2</font> <font color="red">C._2</font> <font color="red">difficile_2</font> <font color="red">whey_2</font> <font color="red">protein_2</font> <font color="red">concentrate_2</font> <font color="red">(_2</font> <font color="red">anti_2</font> <font color="red">-_2</font> <font color="red">CD_2</font> <font color="red">WPC_2</font> <font color="red">)_2</font> is supported by analytical data comparing the composition of <font color="red">raw_1</font> <font color="red">milk_1</font> <font color="red">from_1</font> <font color="red">immunized_1</font> <font color="red">cows_1</font> <font color="red">versus_1</font> <font color="red">that_1</font> <font color="red">from_1</font> <font color="red">non_1</font> <font color="red">-_1</font> <font color="red">immunized_1</font> <font color="red">cows_1</font> <font color="red">,_1</font> and the composition of <font color="red">anti_2</font> <font color="red">-_2</font> <font color="red">CD_2</font> <font color="red">WPC_2</font> versus that of <font color="red">regular_2</font> <font color="red">whey_2</font> <font color="red">protein_2</font> <font color="red">concentrate_2</font> <font color="red">._2</font> Additionally , a prospective clinical study was conducted in 77 patients with CDAD to demonstrate the safety of consuming <font color="red">anti_2</font> <font color="red">-_2</font> <font color="red">CD_2</font> <font color="red">WPC_2</font> to prevent relapse of the infection . This study , which included adverse event monitoring , physical examinations , and extensive hematological and biochemical assessments , showed that <font color="red">anti_2</font> <font color="red">-_2</font> <font color="red">CD_2</font> <font color="red">WPC_2</font> is safe to consume by patients with CDAD . The available analytical and clinical evidence demonstrate that <font color="red">anti_2</font> <font color="red">-_2</font> <font color="red">CD_2</font> <font color="red">WPC_2</font> is safe for use by individuals with CDAD , under the described conditions of use .